Product Information
IBUPROFEN 800 MG TABLET is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $0.0603 per EA under NDC 71921018201. Its NADAC has been published 160 times since Feb 16, 2022.
FDA first approved this application on Oct 15, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Florida Pharmaceutical Products, LLCNDC
71921018201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA071268FDA Approved
10/15/1986
TE Code
AB
On Market Since
10/21/2021
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 800 MG TABLET has been published 160 times since Feb 16, 2022, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0603 per EA |
|---|---|
| All-time high | $0.0748 (Apr 13, 2022) |
| All-time low | $0.0511 (Nov 20, 2024) |
| Median price | $0.0673 |
| Average price | $0.0668 |
| Largest weekly change | -20.3% (Apr 17, 2024) |
| Weeks tracked | 160 |
| Tracking since | Feb 16, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-7.1%
5Y
N/A
All
-17.9%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Florida Pharmaceutical Products, LLC, is $0.0603 per EA (NDC 71921018201), effective Mar 5, 2025.
How has the price of IBUPROFEN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has declined 17.9%. It has been tracked across 160 weekly CMS publications since Feb 16, 2022.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?
Since Feb 16, 2022, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0511 (Nov 20, 2024) to a high of $0.0748 (Apr 13, 2022), with a median of $0.0673 per EA.
Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?
Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 800 MG TABLET, is $0.0567 per EA — about 6% below IBUPROFEN 800 MG TABLET.
Who manufactures IBUPROFEN 800 MG TABLET?
IBUPROFEN 800 MG TABLET (NDC 71921018201) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.